Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Négrier

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Bulletin Du Cancer|April 1, 1997
[Melanoma: a new interferon is coming ... handle with care!]S Négrier
La Revue Du Praticien|October 22, 1998
[Is interleukin 2 useful in oncology?]S Négrier
Bulletin Du Cancer|February 15, 2001
[New guidelines for evaluating the therapeutic response of solid tumors: try them!]S Négrier
Presse Medicale (Paris, France : 1983)|August 3, 2000
[Recommendations for the management of patients with skin melanoma]S Négrier
Bulletin Du Cancer|February 25, 1999
[Cytokines and cancer: update in 1998]S Négrier
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 28, 2008
Temsirolimus in metastatic renal cell carcinomaS Négrier
Annales D'Urologie|January 1, 1993
[Has interleukin 2 modified the outcome of metastatic kidney cancer?]S Négrier, T Philip
Case Reports in Oncology|December 16, 2011
Addition of bevacizumab to temsirolimus in kidney cancer patientsH Boyle, S Négrier
Annales De Chirurgie|January 1, 1992
[Has interleukin 2 modified the outcome of metastatic renal cancer?]S Négrier, T Philip
Bulletin Du Cancer|April 27, 2010
[Management of side effects associated with antiangiogenic treatment in renal cell carcinoma]A Fléchon, H Boyle, S Négrier
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Bulletin Du Cancer|April 1, 1997
[Melanoma: a new interferon is coming ... handle with care!]S Négrier
La Revue Du Praticien|October 22, 1998
[Is interleukin 2 useful in oncology?]S Négrier
Bulletin Du Cancer|February 15, 2001
[New guidelines for evaluating the therapeutic response of solid tumors: try them!]S Négrier
Presse Medicale (Paris, France : 1983)|August 3, 2000
[Recommendations for the management of patients with skin melanoma]S Négrier
Bulletin Du Cancer|February 25, 1999
[Cytokines and cancer: update in 1998]S Négrier
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 28, 2008
Temsirolimus in metastatic renal cell carcinomaS Négrier
Annales D'Urologie|January 1, 1993
[Has interleukin 2 modified the outcome of metastatic kidney cancer?]S Négrier, T Philip
Case Reports in Oncology|December 16, 2011
Addition of bevacizumab to temsirolimus in kidney cancer patientsH Boyle, S Négrier
Annales De Chirurgie|January 1, 1992
[Has interleukin 2 modified the outcome of metastatic renal cancer?]S Négrier, T Philip
Bulletin Du Cancer|April 27, 2010
[Management of side effects associated with antiangiogenic treatment in renal cell carcinoma]A Fléchon, H Boyle, S Négrier
Pageof 6